Shilpa Medicare Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: SHILPAMED BSE: 530549

₹1047.20

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #29 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
Shilpa Medicare Limited (this stock)	20,481	111.8	9.4%	34.5%	—	78	0	55

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹20,602 Cr

EV / EBITDA

79.6x

EV / Sales

29.82x

Market cap / Sales

29.65x

Earnings yield

0.89%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 199 Cr, up 80.2% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	189	51	65	₹3.3200
March 31, 2026	201	78	71	₹3.6300
Dec. 31, 2025	166	24	16	₹0.8400
Sept. 30, 2025	135	39	31	₹1.5800
June 30, 2025	92	15	21	₹2.1200
March 31, 2025	126	-9	-5	₹-0.5300
Sept. 30, 2024	130	51	30	₹3.1200
June 30, 2024	96	41	28	₹2.9400
March 31, 2024	87	11	10	₹1.1200
Dec. 31, 2023	64	4	3	₹0.3100
Sept. 30, 2023	75	12	7	₹0.7600
June 30, 2023	84	11	8	₹0.9100
March 31, 2023	66	-27	-29	₹-3.3300

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Total income (before exceptional items)	199	208	177	152	110	140	151	128	111	86	97	105	87
Operating revenue	189	201	166	135	92	126	130	96	87	64	75	84	66
Other income	10	7	11	17	18	14	21	31	23	22	23	21	20
Operating expenses	133	141	135	96	75	91	87	72	80	67	67	68	80
Operating profit	56	60	31	39	17	35	43	24	7	-3	7	15	-14
Operating profit margin	29.6%	29.7%	18.7%	29.0%	18.4%	27.9%	33.0%	24.9%	8.0%	-5.2%	9.8%	18.3%	-20.7%
Depreciation	15	14	14	13	13	12	12	12	12	12	13	12	12
Interest	3	3	3	2	2	2	1	2	3	3	5	7	7
Exceptional items, gain / (loss)	4	28	-2	-2	-5	-44	-0	-0	-4	-0	-0	-6	-15
Profit before tax	51	78	24	39	15	-9	51	41	11	4	12	11	-27
Tax	-14	7	8	8	-6	-4	20	12	2	1	5	3	2
Net profit	—	71	—	—	—	—	30	28	10	3	7	8	-29
EPS	3.32	3.63	0.84	1.58	2.12	-0.53	3.12	2.94	1.12	0.31	0.76	0.91	-3.33
Net profit (TTM)	—	—	—	—	—	—	71	47	27	-12	-19	—	—
EPS (TTM)	9.37	8.17	4.01	6.29	7.65	6.65	7.49	5.13	3.10	-1.35	-2.21	-5.23	-5.70

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	597	148	133
March 31, 2025	477	107	70

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	27.1%	-5.5%	650^†	—	399^†	316^†	918^†	864^†	817^†	680^†	769^†	755^†
Operating revenue	34.1%	-6.4%	597	477	310^†	248^†	876^†	830^†	806^†	664^†	745^†	735^†
Other income	—	—	53^†	—	89^†	69^†	42^†	34^†	11^†	16^†	24^†	21^†
Operating expenses	—	—	447^†	—	283^†	292^†	716^†	603^†	570^†	490^†	—	550^†
Operating profit	—	-8.0%	150^†	—	26^†	-44^†	159^†	227^†	236^†	174^†	—	185^†
Operating profit margin	—	—	25.1%^†	—	8.5%^†	-17.8%^†	18.2%^†	27.3%^†	29.3%^†	26.2%^†	—	25.2%^†
Depreciation	—	—	54^†	—	50^†	47^†	50^†	41^†	38^†	37^†	—	26^†
Interest	—	—	10^†	—	17^†	21^†	23^†	17^†	4^†	3^†	2^†	3^†
Exceptional items, gain / (loss)	—	—	19^†	—	-10^†	-16^†	9^†	53^†	-5^†	6^†	0^†	-5^†
Profit before tax	—	-10.3%	148	107	38^†	-58^†	137^†	256^†	201^†	156^†	172^†	170^†
Tax	—	—	17^†	—	11^†	-9^†	35^†	71^†	40^†	31^†	37^†	44^†
Net profit	—	-6.3%	133	70	27^†	—	—	184^†	—	124^†	135^†	127^†
EPS	—	-18.4%	8.17^†	—	3.10^†	-5.70^†	12.45^†	22.62^†	19.76^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	25.1%^†	—	8.5%^†	-17.8%^†	18.2%^†	27.3%^†	29.3%^†	26.2%^†	—	25.2%^†
EBIT margin	26.5%^†	—	17.9%^†	-15.1%^†	18.3%^†	32.9%^†	25.5%^†	23.9%^†	23.4%^†	23.5%^†
PBT margin	24.8%	22.5%	12.3%^†	-23.5%^†	15.7%^†	30.8%^†	24.9%^†	23.4%^†	23.1%^†	23.2%^†
Net margin	22.3%	14.6%	8.7%^†	—	—	22.2%^†	—	18.7%^†	18.1%^†	17.2%^†
Interest coverage	15.75x^†	—	3.21x^†	-1.80x^†	6.93x^†	15.63x^†	47.40x^†	54.78x^†	84.48x^†	65.39x^†
Dividend payout	—	—	—	—	—	—	—	—	—	—
Earnings retention	—	—	—	—	—	—	—	—	—	—
Current ratio	1.90x	2.10x	—	—	—	—	—	—	—	—
Quick ratio	1.27x	1.45x	—	—	—	—	—	—	—	—
Debt to equity	0.05x	0.04x	—	—	—	—	—	—	—	—
Return on equity	4.9%	2.6%	—	—	—	—	—	—	—	—
Return on assets	4.4%	2.3%	—	—	—	—	—	—	—	—
Return on capital employed	5.7%^†	—	—	—	—	—	—	—	—	—
Asset turnover	0.20x	0.16x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	60	-67	14	127	-67
March 31, 2025	-19	-433	450	57	-77

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	3,029	2,713	2,694	116	14	526	276	9	463	175
March 31, 2025	3,007	2,701	2,691	82	24	477	227	3	441	149

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.